Featured Research

from universities, journals, and other organizations

A New Approach Holds Promise For Reducing Cocaine Craving

Date:
December 12, 2002
Source:
American College Of Neuropsychopharmacology
Summary:
New understanding of the changes in brain chemistry caused by chronic cocaine use has suggested a novel treatment that could reduce the intense craving that forms the core of cocaine addiction.

New understanding of the changes in brain chemistry caused by chronic cocaine use has suggested a novel treatment that could reduce the intense craving that forms the core of cocaine addiction.

"Our studies show that administration of an existing drug – n-acetyl cysteine, which is used to treat cystic fibrosis and several other disorders – reverses the changes in brain chemistry that appear to cause cocaine craving," said David A. Baker, a post-doctoral fellow in the laboratory of Peter W. Kalivas at the Medical University of South Carolina.

Baker presented the latest results from the Kalivas group's studies of the effects of cocaine in a region of the brain called the nucleus accumbens, which has been associated with motivation, at the annual meeting of the American College of Neuropsychopharmacology in San Juan, Puerto Rico. The initial studies were done in rats, but the results have been so promising that Kalivas and his colleagues are designing experiments to see if this effect carries over to humans.

Previous studies have found that cocaine addiction interferes with the levels of the common neurotransmitter glutamate in the nucleus accumbens. Normally, the neurons are bathed in high levels of glutamate, which tends to reduce their sensitivity so that they fire less frequently. When cocaine is withdrawn after repeated exposures, however, glutamate levels plunge to about half their normal level. During the withdrawal stage, injections of small amounts of cocaine produce large increases in glutamate concentrations, but only for short periods.

The Kalivas group has located a novel target of cocaine's action: a special protein complex, called the cysteine-glutamate antiporter, that pumps glutamate out of the interior of neurons and into the region between them. Most neurotransmitters are ejected into the synapse between two neurons when the neuron fires. However, Baker and Kalivas have determined that more than 60 percent of the extracellular glutamate is produced by antiporters that are located along the sides of the neurons outside the synaptic region.

"It appears that cocaine treatments reduce glutamate levels by suppressing anti-porter activity," says Baker, "and treatment with n-acetyl cysteines not only restores glutamate to normal levels but also prevents glutamate levels from spiking following subsequent cocaine injections."

Cocaine's effect on glutamate levels in the nucleus accumbens have been associated to cocaine addiction through the reinstatement paradigm in rats, which many researchers think is the best animal model for drug-induced craving and relapse in humans.

In this animal model, rats are trained to self-administer cocaine injections by pressing a lever. Once a rat's behavior becomes stable – in about two weeks –the cocaine is replaced with saline causing withdrawal. It generally takes a rat two to three weeks before they stop pressing the lever in hopes of getting more cocaine. If the rats are given a single injection of cocaine, they begin the lever-pressing behavior again. Similarly, extreme stress can cause a rat to return to lever pressing.

Previous studies have shown that blockage of glutamate receptors in the nucleus accumbens before administration of cocaine prevents the rats from returning to lever pressing. This is interpreted as preventing a return of cocaine craving. In the current study, post-doctoral fellow Krista McFarland found that treatment with n-acetyl cysteine had the same preventative effect.

The study was supported by funds from the National Institute on Drug Abuse and the National Institute of Mental Health.

The American College of Neuropsychopharmacology (ACNP) is a professional organization of some 600 leading scientists that was founded in 1961. Members are selected primarily on the basis of their original research contributions to the field of neuropsychopharmacology, which involves the evaluation of the effects of natural and synthetic compounds on the brain, mind and human behavior. The principal functions of the College are research and education. ACNP's annual meeting is limited to participants from around the world who have made major research or clinical contributions in the field.


Story Source:

The above story is based on materials provided by American College Of Neuropsychopharmacology. Note: Materials may be edited for content and length.


Cite This Page:

American College Of Neuropsychopharmacology. "A New Approach Holds Promise For Reducing Cocaine Craving." ScienceDaily. ScienceDaily, 12 December 2002. <www.sciencedaily.com/releases/2002/12/021212081018.htm>.
American College Of Neuropsychopharmacology. (2002, December 12). A New Approach Holds Promise For Reducing Cocaine Craving. ScienceDaily. Retrieved July 25, 2014 from www.sciencedaily.com/releases/2002/12/021212081018.htm
American College Of Neuropsychopharmacology. "A New Approach Holds Promise For Reducing Cocaine Craving." ScienceDaily. www.sciencedaily.com/releases/2002/12/021212081018.htm (accessed July 25, 2014).

Share This




More Mind & Brain News

Friday, July 25, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Beatings and Addiction: Pakistan Drug 'clinic' Tortures Patients

Beatings and Addiction: Pakistan Drug 'clinic' Tortures Patients

AFP (July 24, 2014) A so-called drugs rehab 'clinic' is closed down in Pakistan after police find scores of ‘patients’ chained up alleging serial abuse. Duration 03:05 Video provided by AFP
Powered by NewsLook.com
New Painkiller Designed To Discourage Abuse: Will It Work?

New Painkiller Designed To Discourage Abuse: Will It Work?

Newsy (July 24, 2014) The FDA approved Targiniq ER on Wednesday, a painkiller designed to keep users from abusing it. Like any new medication, however, it has doubters. Video provided by Newsy
Powered by NewsLook.com
Can Watching TV Make You Feel Like A Failure?

Can Watching TV Make You Feel Like A Failure?

Newsy (July 24, 2014) A study by German researchers claims watching TV while you're stressed out can make you feel guilty and like a failure. Video provided by Newsy
Powered by NewsLook.com
China's Ageing Millions Look Forward to Bleak Future

China's Ageing Millions Look Forward to Bleak Future

AFP (July 24, 2014) China's elderly population is expanding so quickly that children struggle to look after them, pushing them to do something unexpected in Chinese society- move their parents into a nursing home. Duration: 02:07 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

    Health News

      Environment News

        Technology News



          Save/Print:
          Share:

          Free Subscriptions


          Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

          Get Social & Mobile


          Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

          Have Feedback?


          Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
          Mobile: iPhone Android Web
          Follow: Facebook Twitter Google+
          Subscribe: RSS Feeds Email Newsletters
          Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins